Valuation: CellaVision AB

Market Cap 3.96B 400M 356M 330M 299M 562M 37.89B 571M 1.56B 19.83B 1.5B 1.47B 63.26B P/E 2026 *
28.5x
P/E 2027 * 22.1x
Enterprise Value 3.77B 381M 339M 314M 285M 535M 36.08B 544M 1.48B 18.88B 1.43B 1.4B 60.23B EV / Sales 2026 *
4.82x
EV / Sales 2027 * 4.24x
Free-Float
81.06%
Yield 2026 *
1.66%
Yield 2027 * 1.94%
1 day-1.14%
1 week-1.21%
Current month-5.43%
1 month-1.80%
3 months+10.08%
6 months+3.15%
Current year+4.20%
1 week 160.8
Extreme 160.8
168.4
1 month 160.6
Extreme 160.6
180.6
Current year 117.6
Extreme 117.6
180.6
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
459
10 years 75.25
Extreme 75.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
9/14/26 Buy

Chief Executive Officer

8,077 0.0339%
9/2/26 Free 100,000 0.4193%
4/28/26 Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
-1.33%-1.21%-10.20%+31.46% 400M
+1.44%+3.71%+26.45%+48.09% 251B
+0.31%+1.02%+8.03%+9.37% 158B
+1.03%+4.16%-4.11%+64.71% 153B
+0.77%+4.91%-54.80%-9.22% 65.29B
+1.00%+3.81%-14.33%-9.91% 51.23B
+1.50%+6.54%+12.40%+60.37% 51.29B
+0.75%+3.26%+16.95%+26.73% 50.27B
+2.20%+1.24%+21.48%+59.04% 47.9B
+2.65%+3.90%+29.93%+75.80% 42.67B
Average +1.06%+2.13%+3.18%+35.64% 87.11B
Weighted average by Cap. +1.19%+2.64%+7.76%+37.73%

Financials

2026 *2027 *
Net sales 782M 78.95M 70.27M 65.13M 59.02M 111M 7.48B 113M 307M 3.91B 296M 290M 12.49B 879M 88.79M 79.03M 73.25M 66.37M 125M 8.41B 127M 345M 4.4B 333M 326M 14.04B
Net income 139M 14.02M 12.48M 11.56M 10.48M 19.69M 1.33B 20.02M 54.5M 695M 52.57M 51.48M 2.22B 181M 18.33M 16.31M 15.12M 13.7M 25.75M 1.74B 26.18M 71.27M 909M 68.74M 67.32M 2.9B
Net Debt -189M -19.14M -17.04M -15.79M -14.31M -26.9M -1.81B -27.35M -74.44M -949M -71.81M -70.32M -3.03B -230M -23.24M -20.68M -19.17M -17.37M -32.64M -2.2B -33.19M -90.35M -1.15B -87.16M -85.35M -3.67B
Projected Income Statement - Annual - CellaVision AB
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
26-10-20 SEK 163.80 -1.33% 26,796
26-10-19 SEK 166.00 -1.43% 16,721
26-10-16 SEK 168.40 +1.08% 24,153
26-10-15 SEK 166.60 +1.34% 44,466
26-10-14 SEK 164.40 -0.84% 74,794
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - CellaVision AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
166.00SEK
Average target price
181.67SEK
Spread / Average Target
+9.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CellaVision AB
  1. Stock Market
  2. Stocks
  3. CEVI Stock